Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352645 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser
A NA study of Plaque Induced Gingivitis, sponsored by Tufts University.
- Recruiting
- Registry status
- NA
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT06352645: Recruiting NA study of Plaque Induced Gingivitis, sponsored by Tufts University.
NCT06352645 is a NA study of Plaque Induced Gingivitis that is actively recruiting participants, run by Tufts University. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06352645, a NA study of Plaque Induced Gingivitis, is actively recruiting participants, sponsored by Tufts University.
- RECRUITING
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the present randomized controlled trial is to evaluate the safety and efficacy of the use of Bixdo A30 Pro Ultra Compact Water Flosser (also referred to as the "Bixdo A30 Portable Water Flosser Travel Set") in addition to a manual toothbrush on clinical parameters of inflammation and bacterial plaque removal.
Primary Outcome
At each of the three study visits, the examiners will conduct a periodontal clinical exam, following standard of care procedure, to evaluate the levels of inflammation in the gingiva of subjects in both the intervention and control groups.
Conditions Studied
Interventions
- DEVICE Bixdo Ultra Compact Water Flosser
- DEVICE Manual toothbrush
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2025-03-04 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06352645 shows while recruiting
NCT06352645 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Plaque Induced Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which Bixdo Ultra Compact Water Flosser is the first listed.
NCT06352645 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06352645 about?
NCT06352645 is a clinical study titled "Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser". The objective of the present randomized controlled trial is to evaluate the safety and efficacy of the use of Bixdo A30 Pro Ultra Compact Water Flosser (also referred to as the "Bixdo A30 Portable Water Flosser Travel Set") in addition to a manual toothbrush on clinical parameters of inflammation an...
What is the current status of trial NCT06352645?
This trial is currently recruiting. It is a NA study. The enrollment target is 165 participants. The study started on 2025-03-04. Estimated completion is 2026-12-31.
What conditions does trial NCT06352645 study?
This clinical trial studies the following conditions: Plaque Induced Gingivitis.
What interventions are being tested in trial NCT06352645?
The interventions under investigation include: Bixdo Ultra Compact Water Flosser (DEVICE), Manual toothbrush (DEVICE).
Who is sponsoring clinical trial NCT06352645?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06352645 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plaque Induced Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06352645's enrollment target sits among peer trials
165 626th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI